ArticleScientific reports2025
Diagnostic accuracy of stool based Xpert MTB/RIF ultra assay for diagnosis of pulmonary tuberculosis in children, Northwest Ethiopia.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Diagnosing childhood pulmonary tuberculosis (PTB) presents unique challenges, including paucibacillary disease, difficulties in specimen collection, and limited diagnostics. Hence, millions of children with tuberculosis (TB) infection remain underdiagnosed. Therefore, our research team evaluated diagnostic accuracy of stool-based Xpert ultra for detecting PTB in children. Five ml respiratory and 3 g stool specimens were analyzed. Strict adherence to laboratory standard operating procedures were warranted. Diagnostic performance of stool Xpert Ultra was compared against Xpert ultra and culture on respiratory samples, and composite reference standards. Of 557 children recruited; 510 had complete microbiological results. PTB was diagnosed in 52/510 (10.2%) children with presumptive TB. Four had microbiologically unconfirmed PTB, who were clinically diagnosed with positive response to anti-TB, remaining 48 were confirmed microbiologically. Stool specimen Xpert ultra had sensitivity 95.8%(95%CI: 82.8-98.6) and specificity of 99.8% (95%CI: 98.7-100) compared to culture; yet, sensitivity of stool was 88.5% (95%CI: 72-95.6) and specificity 100% (95%CI: 99.2-100) when compared to CRS. Xpert ultra on respiratory specimen had sensitivity and specificity 97.9% (95%CI: 85.8- 99.5) and 99.8% (95%CI: 98.7-100) compared to culture and 92.3%(95%CI: 81.4-97.9) and 100% (95%CI: 99.2-100) compared to CRS. Thus, stool samples present promising alternative for diagnosing PTB in children when respiratory specimens cannot be obtained.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.